INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-90 Cr | ₹-71 Cr | ₹-67 Cr | ₹-69 Cr | ₹-37 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDEGENE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-90 Cr |
| Mar2024 | ₹-71 Cr |
| Mar2023 | ₹-67 Cr |
| Mar2022 | ₹-69 Cr |
| Mar2021 | ₹-37 Cr |
How is Deferred Tax Assets / Liabilities of INDEGENE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-90 Cr | Negative | |
| Mar2024 | ₹-71 Cr | Negative | |
| Mar2023 | ₹-67 Cr | Negative | |
| Mar2022 | ₹-69 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,484.8 Cr | -0.1% | -2.1% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,782.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,376.0 Cr | -1.3% | -1.2% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,225.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,174.0 Cr | -0.3% | -1.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,629.0 Cr | -1.2% | -1.8% | -7.7% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -0.1% |
-2.1% |
-13.4% |
| SENSEX | -0.3% |
-0.5% |
8.3% |
You may also like the below Video Courses